Puma Biotech Shares Are Roaring On An FDA Review. Here ' s What Could Still Go Wrong

Puma ' s having a great day, with its stock up 35%. Is it time to pounce? Take a look at what could go wrong at the company ' s FDA hearing on Wednesday, first.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: NASDAQ:PBYI Source Type: news